Related Headline News and Top Stories
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses her2 - 22-24 the results of this phase 3 clinical trial indicate that trastuzumab, when added to conventional chemotherapy, can benefit patients with metastatic breast cancer that overexpresses her2. as compared with the best available standard chemotherapy.
Recomended News to Read
USDAILY – New York City will be full of planet-saving pomp this coming week, but short on action to rescue the world. More than 120 world leaders convene Tuesday for a U.N. summit aimed at galvanizing political will for a new global climate treaty by the end of 2015. Environmentalists will take to the streets […]
Wildfire expert Jim Paxon discusses the skills and heroism of the Granite Mountain Hotshots team, who died fighting the Yarnell Hill Fire. USDAILY – YARNELL, Ariz. — Nineteen elite firefighters who died battling a fast-moving wildfire here Sunday in the country’s worst wildfire disaster in 80 years have been hailed by President Obama as “heroes.” In […]